Posts

Showing posts with the label Hyperkalemia Treatment

Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...

Hyperkalemia Treatment Market Analysis, Dynamics and Regional Insights

Image
Hyperkalemia is a condition in which potassium levels in the blood serum are greater than usual (between 3.5 and 5.0 mmol/L). The kidneys are in charge of maintaining potassium equilibrium in the body by controlling both its excretion and intake. When a person's potassium consumption surpasses his or her kidneys' ability to eliminate it, hyperkalemia develops. The appropriate amount of potassium and sodium in the body is critical for the myocardium's regular function. Congestive heart failure, chronic renal disease, and diabetic kidney disease can all cause hyperkalemia. When a patient takes renin-angiotensin-aldosterone system inhibitors (RAAS) for renal illness, the syndrome can develop. Potassium deficiency can cause irregular heartbeats, which can be fatal. Hyperkalemia Treatment Market– Dynamics During the projected period, the prevalence of cardiac arrhythmias and chronic renal disease would be important drivers driving the hyperkalemia therapy market. Chronic k...

Hyperkalemia Treatment Market Overview, Dynamics and Regional Insights

Image
Hyperkalemia is a condition in which potassium levels in the blood serum are greater than usual (between 3.5 and 5.0 mmol/L). The kidneys are in charge of maintaining potassium equilibrium in the body by controlling both its excretion and intake. When a person's potassium consumption surpasses his or her kidneys' ability to eliminate it, hyperkalemia develops. The appropriate amount of potassium and sodium in the body is critical for the myocardium's regular function. Congestive heart failure, chronic renal disease, and diabetic kidney disease can all cause hyperkalemia. When a patient takes renin-angiotensin-aldosterone system inhibitors (RAAS) for renal illness, the syndrome can develop. Potassium deficiency can cause irregular heartbeats, which can be fatal. Kidney function testing, creatinine blood tests, blood tests, and glucose monitoring are all used to identify hyperkalemia. Hyperkalemia Treatment Market– Dynamics During the projected period, the prevalence of...

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Malaria Vaccines Market – Making Way for a Malaria-Free World

Global and China Catheter Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027